Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contribution of Diffusion Tensor Imaging and Tractography in Primary and Secondary Brain Tumors Evaluation

NCT05261724 is registered in ClinicalTrials.gov with George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures as lead sponsor.

NCT NCT05261724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05261724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contribution of Diffusion Tensor Imaging and Tractography in Primary and Secondary Brain Tumors Evaluation
Lead sponsor
George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures
Phase
Observational
Overall status
Unknown status
Start date
February 15, 2021
Completion date
March 14, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diffusion tensor imaging, mri, tractography